News Snapshot:
By Pedro Fonseca RIO DE JANEIRO (Reuters) - Brazilian regulator Anvisa on Friday authorized a biomedical center to import 6 million doses of the Sinovac coronavirus vaccine, one day after President Jair Bolsonaro said Brazil would not buy the Chinese vaccine. Sao Paulo's Butantan Institute plans to initially import Sinovac's vaccine, which is in phase 3 trials conducted with the help of a local university and not yet approved for wider use in Brazil. Butantan would ultimately manufacture the vaccine if proven effective. Brazil's Sao Paulo governor João Doria said earlier on Friday that Anvisa told him it will not...
